HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.
about
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptionsPersistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviralAssessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.
P2860
HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@en
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@nl
type
label
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@en
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@nl
prefLabel
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@en
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@nl
P2093
P2860
P356
P1476
HCV-specific immune responses ...... ion with IFN-α plus ribavirin.
@en
P2093
Angel Pérez Aguiar
Anny Armas
Carmen Valenzuela
Claudia Vasallo
Czeslaw Wychowski
Daylen Aguilar-Noriega
Gillian Martínez-Donato
Ismariley Revé
Ivette Raíces
Ivis Guerra
P2860
P304
P356
10.3748/WJG.V20.I1.148
P407
P577
2014-01-01T00:00:00Z